Merck

Merck KGaA Expands Spanish Biotech Site

Merck KGaA Targets €4 Billion in New Product Sales

Merck to Market JenKem’s PEG products

Merck KGaA Opens Darmstadt OLED Plant

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

The Winning Formula

Merck and Nanoco Sign Quantum Materials Deal

Merck KGaA With LC Window Plans

EMA to Review Merck KGaA’s MS Tablets MAA

Germany’s Merck Builds US Life Science Center

Germany’s Merck Expands Venture Capital Fund

Addressing The Pharma Innovation Gap

Opdivo from BMS Wins Another US Approval

Logistics Outsourcing has become Common

About 10 years ago, CHEManager decided to present discussions about logistics as a separate theme. Since then, the terms “chemical logistics” and “pharmaceutical logistics” have become established in business and science and with trade associations.

Millipore Sigma Expands cGMP Capacity

Breakthrough Status for Keytruda in Blood Cancer

Maya Martinez-Davis to Head Oncology at Merck KGaA

After Pharma’s Patent Cliff

Merck Extends Pact with Weizmann Institute

GSK Fined for Blocking Copies of Seroxat

Drug Firms Urge Governments to Fight Superbugs

Merck Appoints Executive Board Members

Merck Wins Ruling Against Merck

New Immunotherapy Coalition Launched in US

KPMG Expects 2016 to become Another Record Year for M&A in the Pharmaceutical Industry

Merck-Pfizer Alliance Joins Syndax on Ovarian Cancer

Will Consolidation Force Bayer’s Hand?

Merck-Pfizer Avelumab gets FDA Breakthrough Therapy Status

Sigma-Aldrich now Part of Merck KGaA

Nov. 18 Closing for Sigma-Aldrich Takeover by Merck KGaA

Codexis Seals Wave 1 of Technology Transfer to US Merck

Sigma-Aldrich-Honeywell Deal Advances Merck Takeover

Merck Rebranding Drops Serono and Millipore Names

Stefan Oschmann to Head Germany’s Merck

Merck-Pfizer Avelumab on FDA Fast Track